Publications (56)

2021

  1. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

  2. Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 138-146

2015

  1. Synthesis and identification of unprecedented selective inhibitors of CK1ε

    European Journal of Medicinal Chemistry, Vol. 96, pp. 308-317

2014

  1. Dual-stage triterpenoids from an African medicinal plant targeting the malaria parasite

    Bioorganic and Medicinal Chemistry, Vol. 22, Núm. 15, pp. 3887-3890

2013

  1. Sulfated small molecules targeting EBV in Burkitt lymphoma: From in silico screening to the evidence of in vitro effect on viral episomal DNA

    Chemical Biology and Drug Design, Vol. 81, Núm. 5, pp. 631-644

  2. QSAR studies of macrocyclic diterpenes with P-glycoprotein inhibitory activity

    European Journal of Pharmaceutical Sciences, Vol. 48, Núm. 3, pp. 542-553

  3. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 19, pp. 5382-5384

  4. Generation of artificial neural networks models in anticancer study

    Neural Computing and Applications, Vol. 23, Núm. 3-4, pp. 577-582

  5. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach

    Biochemical Pharmacology, Vol. 85, Núm. 9, pp. 1234-1245

2012

  1. Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones

    Biochemical Pharmacology, Vol. 83, Núm. 1, pp. 57-68